Demographic and Clinical Factors that Influence the Visual Response to Anti-Vascular Endothelial Growth Factor Therapy in Patients with Neovascular Age-Related Macular Degeneration: A Systematic Review

BACKGROUND: Neovascular age-related macular degeneration (nAMD) is a leading cause of blind registrations in the developed world. Standard therapy includes the use of anti-vascular endothelial growth factor (anti-VEGF) drugs, and whilst the clinical efficacy is well established, there is variability...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Claire R., Hewitt, Catherine E., Lightfoot, Tracy, Gale, Richard P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708557/
https://www.ncbi.nlm.nih.gov/pubmed/32770474
http://dx.doi.org/10.1007/s40123-020-00288-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708557/
https://www.ncbi.nlm.nih.gov/pubmed/32770474
http://dx.doi.org/10.1007/s40123-020-00288-0

Ejemplares similares